Inventor · disambiguated record
Francesco De Angelis
Also filed as: DE ANGELIS FRANCESCO
16 granted patents·1 pending application·192 citations·filing 1993–2006
93Inventor score
Files withSIGMA TAU IND FARMACEUTI16
Top patents by PatentIndex Score
17 records- 0195US6369073B1Compounds having reversible inhibiting activity of carnitine palmitoyl-transferaseSIGMA TAU IND FARMACEUTI·Filed 2000·Granted Apr 9, 2002·95 cites·21 claims
- 0285US6444701B1Compounds having reversible inhibiting activity of carnitine palmitoyl-transferaseSIGMA TAU IND FARMACEUTI·Filed 2001·Granted Sep 3, 2002·19 cites·20 claims
- 0377US6528684B1Synthesis of (R) and (S) -aminocarnitine and their derivatives starting from D- and L-aspartic acidSIGMA TAU IND FARMACEUTI·Filed 2000·Granted Mar 4, 2003·10 cites·6 claims
- 0473USRE41226ECompounds having reversible inhibiting activity of carnitine palmitoyl-transferaseSIGMA TAU IND FARMACEUTI·Filed 2006·Granted Apr 13, 2010·1 cites·20 claims
- 0573USRE40861ECompounds having reversible inhibiting activity of carnitine palmitoyl-transferaseSIGMA TAU IND FARMACEUTI·Filed 2006·Granted Jul 21, 2009·1 cites·21 claims
- 0673US6420599B2Chemical process for the stereoselective synthesis of R-(-)-carnitineSIGMA TAU IND FARMACEUTI·Filed 2000·Granted Jul 16, 2002·7 cites·1 claims
- 0772US6822115B2Synthesis of (R) and (S)-aminocarnitine, (R) and (S)-4-phosphonium-3-amino-butanoate, (R) and (S) 3,4-diaminobutanoic acid, and their derivatives starting from D- and L-aspartic acidSIGMA TAU IND FARMACEUTI·Filed 2003·Granted Nov 23, 2004·8 cites·15 claims
- 0871US5412113AProcess for manufacturing L-(-)-carnitine from a waste product having opposite configurationSIGMA TAU IND FARMACEUTI·Filed 1993·Granted May 2, 1995·10 cites·7 claims
- 0966US5491260AProcess for manufacturing L-(-)-carnitine from derivatives having a configuration opposite to that of L-(-)-carnitineSIGMA TAU IND FARMACEUTI·Filed 1994·Granted Feb 13, 1996·9 cites·19 claims
- 1055US5532409AProcess for producing R-aminocarnitine and S-aminocarnitineSIGMA TAU IND FARMACEUTI·Filed 1994·Granted Jul 2, 1996·5 cites·4 claims
- 1154US5925369ABis alkanoyl esters of carnitine having bactericidal, fungicidal and antiprotozoal activityFiled 1997·Granted Jul 20, 1999·15 cites·11 claims
- 1249US5599978AProcess for manufacturing L-(-)-carnitine from a waste product having opposite configurationSIGMA TAU IND FARMACEUTI·Filed 1995·Granted Feb 4, 1997·4 cites·6 claims
- 1347US5532410AProcess for manufacturing L(-)-carnitine from a waste product having opposite configurationSIGMA TAU IND FARMACEUTI·Filed 1994·Granted Jul 2, 1996·4 cites·6 claims
- 1442US6127552AProcess for producing (R)-3-hydroxy-4-butyrolactone useful for preparing (R)-carnitineSIGMA TAU IND FARMACEUTI·Filed 1998·Granted Oct 3, 2000·2 cites·16 claims
- 1542US5714619AProcess for the preparation of (S)-β-hydroxy-γ-butyrolactoneSIGMA TAU IND FARMACEUTI·Filed 1996·Granted Feb 3, 1998·2 cites·6 claims
- 1640US6316667B2Process for the preparation of R-(-)-carnitineSIGMA TAU IND FARMACEUTI·Filed 2000·Granted Nov 13, 2001·0 cites·12 claims
- 1736US2003153783A1Synthesis of (R) and (S)-aminocarnitine, (R) and (S)-4-phosphonium-3-amino-butanoate, (R) and (S) 3,4-diaminobutanoic acid, and their derivatives starting from D- and L-aspartic acidSIGMA TAU IND FARMACEUTI·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Francesco De Angelis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →